Figure 1. Killer cell immunoglobulin-like receptor haplotypes among the control group, Ebola survivors, and persons who died of Ebola virus disease in Guinea, 2015–2017. Percentage of each haplotype was calculated and defined as the number of persons with the killer cell immunoglobulin-like receptor haplotype (n) divided by the number of persons (N) in the studied group. Black boxes indicate presence of genes; white boxes indicate absence of genes. †p<Pc (survivors vs. fatalities). Pc, corrected p value.